Amneal Pharmaceuticals Inc (2DT.MU)
Munich - Munich Delayed price. Currency in EUR
Add to watchlist
At close: 08:02AM CEST
| Previous close | 6.30 |
| Open | 6.30 |
| Bid | 6.20 x N/A |
| Ask | 6.25 x N/A |
| Day's range | 6.30 - 6.30 |
| 52-week range | 2.08 - 6.30 |
| Volume | |
| Avg. volume | 39 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Insider Sale: Director Deborah Autor Sells 38,000 Shares of Amneal Pharmaceuticals Inc (AMRX)
On May 17, 2024, Deborah Autor, Director at Amneal Pharmaceuticals Inc (NASDAQ:AMRX), executed a sale of 38,000 shares of the company.
- Simply Wall St.
Amneal Pharmaceuticals First Quarter 2024 Earnings: US$0.30 loss per share (vs US$0.046 loss in 1Q 2023)
Amneal Pharmaceuticals ( NASDAQ:AMRX ) First Quarter 2024 Results Key Financial Results Revenue: US$659.2m (up 18% from...
- GuruFocus.com
Amneal Pharmaceuticals Inc (AMRX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
Amneal Pharmaceuticals reports significant revenue and EBITDA growth in Q1 2024, driven by new product launches and strong market performance.
© 2024 Yahoo. All rights reserved.